Adaptilens

• 30/04/2024
• Series A
• $17,500,000

Adaptilens is the only IOL that imitates the human eye’s natural lens. We are a team of ophthalmologists, cataract specialists, scientists, and engineers with a singular focus on improving the vision and quality of life of cataract patients. We are developing an accommodating IOL with novel polymers to give patients the ability to focus not just on a single distance but on objects near, far, and in between--without the help of glasses or contact lenses. To stay updated as our life-changing lens technology develops, follow us here or sign up for updates here: https://adaptilens.com/contact/

---

---